AZ
Alan Zettin
Ceo - Chief Executive Officer at Diaco Biofarmaceutici
View Alan's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Ceo - Chief Executive Officer
Present
Company Details
51-200 Employees
In 1967, the Diaco Biopharmaceuticals plant - a milestone in the pharmaceutical industry - was established in Trieste, Italy. It was here where Don Baxter Laboratories started producing blood collection bags and parenteral solutions. In 2014, new ownership brought a breath of fresh air. Today, with technological innovation and advanced manufacturing, Diaco Biofarmaceutici is undergoing a profound process of modernisation. Our product range includes hyaluronic acid-based prefilled syringes, small and large volume sterile parenteral solutions and bag-on-valve products, using state-of-the-art, environmentally friendly technologies. Our bold strategic business plan combines passion, tradition and knowledge with the aim of consolidating ourselves as a leading health and beauty company in Europe and beyond. We are proud that our presence goes beyond our region and our country, reaching not only Europe but also Asia and Latin America.
Year Founded
1967
Social Media
LinkedinFacebook
Industry
Pharmaceutical Manufacturing, Pharmaceutical preparations NES, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Prodotti farmaceutici diversi, non specificati altrove, Salute, prodotti medicinali e farmaceutici, Prodotti chimici, prodotti farmaceutici, materie plastiche, Hospital, medical, dentistry and veterinary equipment (wholesale), General traders, department and retail stores, Retail & Traders
HQ Location
Via Flavia 124 Trieste, Trieste 34147, IT
Keywords
PharmaceuticalCosmeticMedical DeviceHealthInfusionalPharmaOrthopedicsUrologyand Hyaluronic Acid
Discover More About Cleveland Clinic

Find verified contacts of Alan Zettin in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.